Item 5. Market for Registrant’s Common Equity
ITEM
5 – MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our
Common Stock is currently traded on the Nasdaq Capital Market under the symbol “FTFT.” Prior to December 31, 2018, our stock
traded on the Nasdaq Global Market, and before that, on the NYSE Amex.
As of April 12, 2022, there were 70,067,147 shares of our Common Stock
issued and outstanding, and the Company had approximately 57 record holders of Common Stock. The number of holders of record does not
include the number of persons whose stock is in nominee or “street name” accounts through brokers.
Dividend
Policy
We
have never declared or paid any cash dividends on our Common Stock. The payment of dividends is at the discretion of the Board and is
contingent on our revenues and earnings, capital requirements, financial condition and the ability of our operating subsidiaries to obtain
governmental approval to send funds out of the PRC. We currently intend to retain all earnings, if any, for use in business operations.
Accordingly, we do not anticipate declaring any dividends in the near future.
The
PRC’s national currency, the RMB or yuan, is not a freely-convertible currency. Please refer to the Risk Factors “ Governmental
control of currency conversion may affect the value of shareholder investment ,” and “ PRC regulations relating to offshore
investment activities by PRC residents may limit our PRC subsidiary’s ability to increase its registered capital or distribute
profits to us or otherwise expose us or our PRC resident beneficial owners to liability and penalties under PRC law ”.
Recent
Sales of Unregistered Securities and Use of Proceeds
The
Company did not make any sales of unregistered securities during the fiscal year ended December 31, 2021 that were not previously disclosed
in a quarterly report on Form 10-Q or a current report on Form 8-K.
42
Securities
Authorized for Issuance Under Equity Compensation Plans
The
following table sets forth information as of December 31, 2021, with respect to our equity compensation plans previously approved by
stockholders and equity compensation plans not previously approved by stockholders.
Equity
Compensation Plan Information
Plan Category
Number
of
securities
to be issued
upon
exercise of
outstanding
options,
warrants
and rights
Weighted
average
exercise
price of
outstanding
options,
warrants
and rights
Number
of
securities
remaining
available for
future
issuance
under equity
compensation
plans
(excluding
securities
reflected in
column (a))
(a)
(b)
(c)
Equity compensation plans approved
by stockholders (1)
62,500
$ 3.57 (2)
3,047,000
Equity compensation
plans not approved by stockholders
-
$ -
-
Total
$ 3.57
3,047,000
(1)
Consists
of equity incentive plans, which was approved by the Company’s shareholders at its annual or special meetings on August 18,
2011, November 19, 2015, March 13, 2018, February 26, 2020 and December 18, 2020. As of December 31, 2021, there were 3,047,000 shares
available for issuance under stock incentive plan approved by shareholders on December 18, 2020.
The
Board of Directors of the Company approved and adopted the Future FinTech Group Inc. 2019 Omnibus Equity Plan (the “2019 Equity
Plan”) on October 9, 2019, which was approved by the shareholders at the shareholders special meeting on February 26, 2020.
The 2019 Equity Plan has a total of 3,000,000 shares of Common Stock. The Company grant the 3,000,000 shares under 2019 Equity Plan
to nine officers, employees and director of the Company on December 28, 2020.
The
Board of Directors of the Company approved and adopted the Future FinTech Group Inc. 2020 Omnibus Equity Plan (the “2020 Equity
Plan”) on October 27, 2020, which was approved by the shareholders at the shareholders annual meeting on December 18, 2020.
The 2020 Equity Plan has a total of 5,000,000 shares of Common Stock. The Company grant the 1,953,000 shares under 2020 Equity Plan
to sixteen officers and employees of the Company on July 12, 2021.
(2)
The exercise price of options
granted under the plan may be no less than the fair market value of the Company’s Stock on the date of grant.
ITEM
6 – [RESERVED]
Not Applicable.
43